GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LTS:0R1F) » Definitions » Other Current Receivables

Bristol-Myers Squibb Co (LTS:0R1F) Other Current Receivables : $5,578 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Bristol-Myers Squibb Co Other Current Receivables?

Bristol-Myers Squibb Co's Other Current Receivables for the quarter that ended in Sep. 2024 was $5,578 Mil.

Bristol-Myers Squibb Co's quarterly Other Current Receivables increased from Mar. 2024 ($5,234.00 Mil) to Jun. 2024 ($5,400.00 Mil) and increased from Jun. 2024 ($5,400.00 Mil) to Sep. 2024 ($5,578.00 Mil).

Bristol-Myers Squibb Co's annual Other Current Receivables increased from Dec. 2021 ($4,537.00 Mil) to Dec. 2022 ($5,786.00 Mil) and increased from Dec. 2022 ($5,786.00 Mil) to Dec. 2023 ($6,382.00 Mil).

Bristol-Myers Squibb Co Other Current Receivables Historical Data

The historical data trend for Bristol-Myers Squibb Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Other Current Receivables Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,209.00 3,335.00 4,537.00 5,786.00 6,382.00

Bristol-Myers Squibb Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,240.00 6,382.00 5,234.00 5,400.00 5,578.00

Bristol-Myers Squibb Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Bristol-Myers Squibb Co Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LTS:0R1F) » Definitions » Other Current Receivables
Comparable Companies
GILD PFE AMGN BIIB OGN AMRN SCLX MIRA MRK ABBV LLY OCSE:NOVO B JNJ XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 TSE:4568
Traded in Other Exchanges
BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina
Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Website
https://www.bms.com
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines